Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Sep 11;10:4423–4433. doi: 10.2147/OTT.S144015

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Zhao et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Performance assessment of published immune-related risk scores.

Notes: (A) C-indices are given for predictions of overall survival for each of eight models in each of ten microarray data sets (left panel). Data sets used as training data sets during model development are shown in black. Darker shades of orange corresponded to higher prediction levels; 0.5= random risk score, 1.0= perfect prediction. Models are ordered from the highest to the lowest summary C-index (top to bottom). Summary C-indices are given for each model with training data sets excluded (orange boxes; right panel); 95% CIs (gray lines) were obtained by resampling cases. C-indices are presented for predictions of overall survival in ER−, ER+, LN+, and LN− data sets (left panels of B–E, respectively). Summary C-indices in ER−, ER+, LN+, and LN− data sets are given for each model with training data sets excluded (orange boxes; right panels of B–E, respectively).

Abbreviations: C-indices, concordance indices; ER, estrogen receptor; LN, lymph node.

Performance assessment of published immune-related risk scores.

Notes: (A) C-indices are given for predictions of overall survival for each of eight models in each of ten microarray data sets (left panel). Data sets used as training data sets during model development are shown in black. Darker shades of orange corresponded to higher prediction levels; 0.5= random risk score, 1.0= perfect prediction. Models are ordered from the highest to the lowest summary C-index (top to bottom). Summary C-indices are given for each model with training data sets excluded (orange boxes; right panel); 95% CIs (gray lines) were obtained by resampling cases. C-indices are presented for predictions of overall survival in ER−, ER+, LN+, and LN− data sets (left panels of B–E, respectively). Summary C-indices in ER−, ER+, LN+, and LN− data sets are given for each model with training data sets excluded (orange boxes; right panels of B–E, respectively).

Abbreviations: C-indices, concordance indices; ER, estrogen receptor; LN, lymph node.